Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective Non-Interventional Observational Study of Use of Triumeq® and Corresponding Monitoring Measures in Clinical Practice in Germany

NCT02342769 is registered in ClinicalTrials.gov with ViiV Healthcare as lead sponsor.

NCT NCT02342769
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02342769 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective Non-Interventional Observational Study of Use of Triumeq® and Corresponding Monitoring Measures in Clinical Practice in Germany
Lead sponsor
ViiV Healthcare
Phase
Observational
Overall status
Completed
Start date
February 19, 2015
Completion date
October 28, 2018
Enrollment
403 (actual)
Sites
29

Conditions

As the registry lists them; a condition with its own page is linked.

hiv infections